14-day Premium Trial Subscription Try For FreeTry Free
FRA:BV3
Delisted

Bavarian Nordic A/S Stock Price (Quote)

Frankfurt Stock Exchange
Open Broker Account
20.64€
+0 (+0%)
At Close: Dec 22, 2023
Forecast Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days 20.64€ 20.64€ Friday, 22nd Dec 2023 BV3.F stock ended at 20.64€. During the day the stock fluctuated 0% from a day low at 20.64€ to a day high of 20.64€.
90 days 20.18€ 21.17€
52 weeks 18.20€ 35.60€

Historical Bavarian Nordic A/S prices

Date Open High Low Close Volume
Sep 26, 2019 26.41€ 26.41€ 25.72€ 25.80€ 380
Sep 25, 2019 28.06€ 28.06€ 25.84€ 25.84€ 25
Sep 24, 2019 26.13€ 27.59€ 26.13€ 27.59€ 143
Sep 23, 2019 25.81€ 26.30€ 25.81€ 26.30€ 80
Sep 20, 2019 25.66€ 25.69€ 25.60€ 25.69€ 77
Sep 19, 2019 25.25€ 25.25€ 25.15€ 25.15€ 77
Sep 18, 2019 25.08€ 25.08€ 25.08€ 25.08€ 77
Sep 17, 2019 25.03€ 25.06€ 25.03€ 25.06€ 77
Sep 16, 2019 24.57€ 24.80€ 24.46€ 24.80€ 77
Sep 13, 2019 23.67€ 23.67€ 23.53€ 23.53€ 21
Sep 12, 2019 23.68€ 23.68€ 23.53€ 23.53€ 21
Sep 11, 2019 23.25€ 23.44€ 23.25€ 23.44€ 21
Sep 10, 2019 23.18€ 23.18€ 23.18€ 22.78€ 21
Sep 09, 2019 23.87€ 23.87€ 23.87€ 23.31€ 21
Sep 06, 2019 23.91€ 23.91€ 23.80€ 23.80€ 21
Sep 05, 2019 23.84€ 24.64€ 23.92€ 23.92€ 21
Sep 04, 2019 23.84€ 23.84€ 23.84€ 23.84€ 0
Sep 03, 2019 23.05€ 23.66€ 23.05€ 23.66€ 0
Sep 02, 2019 23.60€ 23.60€ 23.60€ 23.60€ 0
Aug 30, 2019 23.71€ 23.88€ 23.71€ 23.88€ 0
Aug 29, 2019 23.69€ 23.74€ 23.69€ 23.74€ 0
Aug 28, 2019 24.33€ 24.33€ 23.57€ 23.57€ 0
Aug 27, 2019 23.93€ 24.82€ 23.93€ 24.82€ 80
Aug 26, 2019 23.22€ 23.22€ 23.22€ 23.22€ 0
Aug 23, 2019 23.36€ 23.36€ 23.21€ 23.26€ 0
Click to get the best stock tips daily for free!

About Bavarian Nordic A/S

Bavarian Nordic A/S Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... BV3.F Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT